Acer Therapeutics reports Q2 EPS ($1.09), consensus (78c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Silverback Therapeutics reports Q1 EPS (54c), consensus (35c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Frequency Therapeutics reports Q1 EPS (60c), consensus (28c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Orchard Therapeutics reports Q1 EPS (31c), consensus (33c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akero Therapeutics reports Q1 EPS (43c), consensus (91c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Chinook Therapeutics reports Q1 EPS (88c), consensus (68c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marker Therapeutics reports Q1 EPS , consensus (14c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viracta Therapeutics reports Q1 EPS ($5.22), consensus (21c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Relmada Therapeutics reports Q1 EPS ($1.34), consensus ($1.39)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Neoleukin Therapeutics reports Q1 EPS (27c), consensus (23c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aileron Therapeutics reports Q1 EPS (8c), consensus (5c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Lyra Therapeutics reports Q1 EPS (60c), consensus (48c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Poseida Therapeutics reports Q1 EPS (62c), consensus (63c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rapt Therapeutics reports Q1 EPS (66c), consensus (62c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Prelude Therapeutics reports Q1 EPS (47c), consensus (42c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBL Therapeutics reports Q1 EPS (12c), consensus (13c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Galera Therapeutics reports Q1 EPS (75c), consensus (83c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Therapeutics reports Q1 EPS ($1.00), consensus ($1.01)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Beam Therapeutics reports Q1 EPS ($3.35), consensus (74c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Design Therapeutics reports Q1 EPS (31c), consensus (7c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sigilon Therapeutics reports Q1 EPS (60c), consensus (59c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»